Arrowhead Research | ARWR - حساب الفائدة على الديون





حساب الفائدة على الديون تغيير تاريخ
Agios Pharmaceuticals USD 1.18B 4.3B 2026-03
Alnylam Pharmaceuticals USD 69.29M 60.05M 2026-03
Anika Therapeutics 179.39M 556.84M 2026-03
Arrowhead Research USD 22.5M 811K 2025-12
Heron Therapeutics USD 600K 100K 2024-12
Incyte USD 569K 13K 2026-03
Ionis Pharmaceuticals USD 17M 1000K 2026-03
Ligand Pharmaceuticals USD 1.78M 875K 2025-12
Merck USD 479M 67M 2026-03
Moderna USD 11.49B 36B 2026-03
Nektar Therapeutics USD 9.77M 3.75M 2025-12
Novartis USD 343M 39M 2026-03
Sarepta Therapeutics USD 20.84M 13.28M 2025-12
TG Therapeutics USD 7.67M 1.13M 2026-03
Ultragenyx Pharmaceutical USD 21M 2M 2026-03
Vertex Pharmaceuticals USD 3.3M 0 2025-12
Xencor USD 4.7M 2.65M 2026-03